<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
	>

<channel>
	<title>THE &#34;NEW&#34;  PROSTATE CANCER INFOLINK &#187; Uncategorized</title>
	<atom:link href="http://prostatecancerinfolink.net/category/uncategorized/feed/" rel="self" type="application/rss+xml" />
	<link>http://prostatecancerinfolink.net</link>
	<description></description>
	<lastBuildDate>Tue, 14 Feb 2012 02:29:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
<cloud domain='prostatecancerinfolink.net' port='80' path='/?rsscloud=notify' registerProcedure='' protocol='http-post' />
<image>
		<url>http://s2.wp.com/i/buttonw-com.png</url>
		<title>THE &#34;NEW&#34;  PROSTATE CANCER INFOLINK &#187; Uncategorized</title>
		<link>http://prostatecancerinfolink.net</link>
	</image>
	<atom:link rel="search" type="application/opensearchdescription+xml" href="http://prostatecancerinfolink.net/osd.xml" title="THE &#34;NEW&#34;  PROSTATE CANCER INFOLINK" />
	<atom:link rel='hub' href='http://prostatecancerinfolink.net/?pushpress=hub'/>
		<item>
		<title>Vigorous exercise may prevent progression of low-risk prostate cancer</title>
		<link>http://prostatecancerinfolink.net/2012/02/02/vigorous-exercise-may-prevent-progression-of-low-risk-prostate-cancer/</link>
		<comments>http://prostatecancerinfolink.net/2012/02/02/vigorous-exercise-may-prevent-progression-of-low-risk-prostate-cancer/#comments</comments>
		<pubDate>Thu, 02 Feb 2012 12:58:34 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Living with Prostate Cancer]]></category>
		<category><![CDATA[Management]]></category>
		<category><![CDATA[Prevention]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[activity]]></category>
		<category><![CDATA[exercise]]></category>
		<category><![CDATA[low risk]]></category>
		<category><![CDATA[preventiuon]]></category>
		<category><![CDATA[progression]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14922</guid>
		<description><![CDATA[The idea that exercise and physicial fitness may be associated with a reduction in risk of disease progression in men with relatively low-risk prostate cancer is hardly new, but a study to be presented today at the Genitourinary Cancer Symposium in San Francisco may put a whole new spin on this idea. Magbanua et al. have [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=prostatecancerinfolink.net&amp;blog=3176292&amp;post=14922&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2012/02/02/vigorous-exercise-may-prevent-progression-of-low-risk-prostate-cancer/feed/</wfw:commentRss>
		<slash:comments>5</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>Dutasteride as a single agent for low-risk prostate cancer</title>
		<link>http://prostatecancerinfolink.net/2012/01/24/dutasteride-as-a-single-agent-for-low-risk-prostate-cancer/</link>
		<comments>http://prostatecancerinfolink.net/2012/01/24/dutasteride-as-a-single-agent-for-low-risk-prostate-cancer/#comments</comments>
		<pubDate>Wed, 25 Jan 2012 01:59:30 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Living with Prostate Cancer]]></category>
		<category><![CDATA[Management]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[dutasteride]]></category>
		<category><![CDATA[low risk]]></category>
		<category><![CDATA[Prevention]]></category>
		<category><![CDATA[progression]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14852</guid>
		<description><![CDATA[According to data just reported in The Lancet, some men with low-volume, low-risk prostate cancer may be able to delay progression of their disease if treated only with the 5α-reductase inhibitor dutasteride (Avodart®). Fleshner et al. conducted a multi-center, randomized, double-blind, placebo-controlled trial (the REDEEM trial) in men aged between 48 and 82 years who [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=prostatecancerinfolink.net&amp;blog=3176292&amp;post=14852&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2012/01/24/dutasteride-as-a-single-agent-for-low-risk-prostate-cancer/feed/</wfw:commentRss>
		<slash:comments>5</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>An update on views about the USPSTF recommendation and prostate cancer screening</title>
		<link>http://prostatecancerinfolink.net/2012/01/18/an-update-on-views-about-the-uspstf-recommendation-and-prostate-cancer-screening/</link>
		<comments>http://prostatecancerinfolink.net/2012/01/18/an-update-on-views-about-the-uspstf-recommendation-and-prostate-cancer-screening/#comments</comments>
		<pubDate>Wed, 18 Jan 2012 21:38:44 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14829</guid>
		<description><![CDATA[Apparently, earlier this week, Congressmen Runyan and Baca (the co-chairmen of the Congressional Prostate Cancer Task Force) sent a letter to Secretary Sebelius about prostate cancer screening. The entire text of this letter can be read if you just click here. The general gist of this letter &#8212; targeted to head off the recent recommendation [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=prostatecancerinfolink.net&amp;blog=3176292&amp;post=14829&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2012/01/18/an-update-on-views-about-the-uspstf-recommendation-and-prostate-cancer-screening/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>Self-referral and the role of IMRT in treatment of prostate cancer</title>
		<link>http://prostatecancerinfolink.net/2012/01/17/self-referral-and-the-role-of-imrt-in-treatment-of-prostate-cancer/</link>
		<comments>http://prostatecancerinfolink.net/2012/01/17/self-referral-and-the-role-of-imrt-in-treatment-of-prostate-cancer/#comments</comments>
		<pubDate>Tue, 17 Jan 2012 20:10:59 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[IMRT]]></category>
		<category><![CDATA[motive]]></category>
		<category><![CDATA[profit]]></category>
		<category><![CDATA[radiation therapy]]></category>
		<category><![CDATA[self-referral]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14813</guid>
		<description><![CDATA[The issue of whether some urology practices are investing in equipment capable of delivering intensity-modulated radiation therapy (IMRT) with financial motives is back on the front burner again. An article in today&#8217;s Baltimore Sun pretty much accuses a particular urology practice of investing in IMRT equipment for financial gain and self-referring patients for IMRT rather [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=prostatecancerinfolink.net&amp;blog=3176292&amp;post=14813&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2012/01/17/self-referral-and-the-role-of-imrt-in-treatment-of-prostate-cancer/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>A small, multi-center cohort study of SBRT in treatment of low-risk prostate cancer</title>
		<link>http://prostatecancerinfolink.net/2012/01/15/a-small-multi-center-cohort-study-of-sbrt-in-treatment-of-low-risk-prostate-cancer/</link>
		<comments>http://prostatecancerinfolink.net/2012/01/15/a-small-multi-center-cohort-study-of-sbrt-in-treatment-of-low-risk-prostate-cancer/#comments</comments>
		<pubDate>Sun, 15 Jan 2012 13:40:46 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Diagnosis]]></category>
		<category><![CDATA[Management]]></category>
		<category><![CDATA[Risk]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[CyberKnife]]></category>
		<category><![CDATA[outcome]]></category>
		<category><![CDATA[SBRT]]></category>
		<category><![CDATA[stereotactic body radiation therapy]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14799</guid>
		<description><![CDATA[Published reports on the safety and efficacy of extreme hypofactionated radiation therapy (stereotactic body radiation therapy or SBRT, a.k.a. CyberKnife radiation therapy) have, to date, come from just a couple of key centers. In a new report, four different centers report as a group on their initial experience of SBRT using the CyberKnife technology with [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=prostatecancerinfolink.net&amp;blog=3176292&amp;post=14799&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2012/01/15/a-small-multi-center-cohort-study-of-sbrt-in-treatment-of-low-risk-prostate-cancer/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>Single genetic mutation predicts risk for one rare form of hereditary prostate cancer</title>
		<link>http://prostatecancerinfolink.net/2012/01/12/single-genetic-mutation-predicts-one-rare-form-of-hereditary-prostate-cancer/</link>
		<comments>http://prostatecancerinfolink.net/2012/01/12/single-genetic-mutation-predicts-one-rare-form-of-hereditary-prostate-cancer/#comments</comments>
		<pubDate>Thu, 12 Jan 2012 14:05:02 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14780</guid>
		<description><![CDATA[According to an article in today&#8217;s New England Journal of Medicine, a rare but recurrent mutation in a gene known as HOXB13 (rs138213197) &#8212; a gene that is important in prostate development &#8212; appears to be responsible for early-onset, familial prostate cancer in some men of European descent. This paper by Ewing et al. appears to [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=prostatecancerinfolink.net&amp;blog=3176292&amp;post=14780&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2012/01/12/single-genetic-mutation-predicts-one-rare-form-of-hereditary-prostate-cancer/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>The scientific basis for PSA monitoring after first-line treatment for localized prostate cancer</title>
		<link>http://prostatecancerinfolink.net/2012/01/12/the-scientific-basis-for-psa-monitoring-after-first-line-treatment-for-localized-prostate-cancer/</link>
		<comments>http://prostatecancerinfolink.net/2012/01/12/the-scientific-basis-for-psa-monitoring-after-first-line-treatment-for-localized-prostate-cancer/#comments</comments>
		<pubDate>Thu, 12 Jan 2012 13:44:08 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Living with Prostate Cancer]]></category>
		<category><![CDATA[Management]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[guideline]]></category>
		<category><![CDATA[monitoring]]></category>
		<category><![CDATA[PSA]]></category>
		<category><![CDATA[recurrence]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14777</guid>
		<description><![CDATA[A new article in the Canadian Medical Association Journal has reported on a careful analysis of the published literature underlying current guidelines on the use of repetitive PSA testing to monitor risk for progression in men receiving first-line treatment for localized prostate cancer. Many patients may be surprised just how few data there are to support [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=prostatecancerinfolink.net&amp;blog=3176292&amp;post=14777&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2012/01/12/the-scientific-basis-for-psa-monitoring-after-first-line-treatment-for-localized-prostate-cancer/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>Are US urologists really acceptant of active surveillance?</title>
		<link>http://prostatecancerinfolink.net/2012/01/10/are-us-urologists-really-acceptant-of-active-surveillance/</link>
		<comments>http://prostatecancerinfolink.net/2012/01/10/are-us-urologists-really-acceptant-of-active-surveillance/#comments</comments>
		<pubDate>Tue, 10 Jan 2012 16:11:44 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Living with Prostate Cancer]]></category>
		<category><![CDATA[Management]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[acceptance]]></category>
		<category><![CDATA[active surveillance]]></category>
		<category><![CDATA[opinion]]></category>
		<category><![CDATA[urologist]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14764</guid>
		<description><![CDATA[According to a new study published on line in Prostate Cancer and Prostatic Diseases, 370/425 urologists who responded to a recent survey felt that active surveillance was a reasonable management strategy and about 350/425 actually manage patients by using this approach. But only 1 in 12 urologists actually responded to this survey. Gorin et al. [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=prostatecancerinfolink.net&amp;blog=3176292&amp;post=14764&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2012/01/10/are-us-urologists-really-acceptant-of-active-surveillance/feed/</wfw:commentRss>
		<slash:comments>19</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>ACS projects incidence and mortality data for 2012</title>
		<link>http://prostatecancerinfolink.net/2012/01/05/acs-projects-incidence-and-mortality-data-for-2012/</link>
		<comments>http://prostatecancerinfolink.net/2012/01/05/acs-projects-incidence-and-mortality-data-for-2012/#comments</comments>
		<pubDate>Thu, 05 Jan 2012 13:41:23 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14721</guid>
		<description><![CDATA[The American Cancer Society (ACS) yesterday released projected data for the incidence and the mortality of prostate cancer for 2012. The bottom line: they are projecting more new cases and significantly fewer deaths than in 2011. In 2011, the ACS projected 240,890 new cases of prostate cancer diagnosis and 33,720 prostate cancer-specific deaths. For 2012 [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=prostatecancerinfolink.net&amp;blog=3176292&amp;post=14721&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2012/01/05/acs-projects-incidence-and-mortality-data-for-2012/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>The &#8220;New&#8221; Prostate Cancer InfoLink: 2011 in review</title>
		<link>http://prostatecancerinfolink.net/2012/01/01/the-new-prostate-cancer-infolink-2011-in-review/</link>
		<comments>http://prostatecancerinfolink.net/2012/01/01/the-new-prostate-cancer-infolink-2011-in-review/#comments</comments>
		<pubDate>Sun, 01 Jan 2012 15:09:44 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14705</guid>
		<description><![CDATA[The WordPress.com stats helper monkeys prepared a 2011 annual report for this blog. Here&#8217;s an excerpt: London Olympic Stadium holds 80,000 people. This blog was viewed about 630,000 times in 2011. If it were competing at London Olympic Stadium, it would take about 8 sold-out events for that many people to see it. Click here [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=prostatecancerinfolink.net&amp;blog=3176292&amp;post=14705&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2012/01/01/the-new-prostate-cancer-infolink-2011-in-review/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>

		<media:content url="http://www.wordpress.com/wp-content/mu-plugins/annual-reports/img/emailteaser.jpg" medium="image" />
	</item>
		<item>
		<title>Magnesium oxide and prostate movement during radiation therapy</title>
		<link>http://prostatecancerinfolink.net/2011/12/24/magnesium-oxide-and-prostate-movement-during-radiation-therapy/</link>
		<comments>http://prostatecancerinfolink.net/2011/12/24/magnesium-oxide-and-prostate-movement-during-radiation-therapy/#comments</comments>
		<pubDate>Sat, 24 Dec 2011 17:28:39 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Management]]></category>
		<category><![CDATA[Treatment]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[antiflatulent]]></category>
		<category><![CDATA[IMRT]]></category>
		<category><![CDATA[magnesium]]></category>
		<category><![CDATA[MgO]]></category>
		<category><![CDATA[motion]]></category>
		<category><![CDATA[oxide]]></category>
		<category><![CDATA[radiation]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14679</guid>
		<description><![CDATA[It has previously been proposed by some researchers that daily dosing with magnesium oxide (MgO) &#8212; alone or as part of an antiflatulent dietary regimen &#8212; can be used to reduce prostate motion (in combination with fiducial markers) during external beam radiation therapy for localized prostate cancer. Lips et al. have now reported data from [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=prostatecancerinfolink.net&amp;blog=3176292&amp;post=14679&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2011/12/24/magnesium-oxide-and-prostate-movement-during-radiation-therapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>DoD CDMRP funding and prostate cancer research for FY 2012</title>
		<link>http://prostatecancerinfolink.net/2011/12/16/dod-cdmrp-funding-and-prostate-cancer-research-for-fy-2012/</link>
		<comments>http://prostatecancerinfolink.net/2011/12/16/dod-cdmrp-funding-and-prostate-cancer-research-for-fy-2012/#comments</comments>
		<pubDate>Fri, 16 Dec 2011 11:47:11 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[CDMRP]]></category>
		<category><![CDATA[research]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14649</guid>
		<description><![CDATA[It appears that research funding of $80 million will again be directed for use to study prostate cancer through the Department of Defense&#8217;s Congressionally Directed Medical Research Program (DoD CDMRP) for the financial year 2012. This is a big and important &#8220;win&#8221; for prostate cancer research during a time of fiscal constraint. Congratulations to all those advocates [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=prostatecancerinfolink.net&amp;blog=3176292&amp;post=14649&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2011/12/16/dod-cdmrp-funding-and-prostate-cancer-research-for-fy-2012/feed/</wfw:commentRss>
		<slash:comments>3</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>The patients&#8217; expectations and the doctors&#8217; dilemmas</title>
		<link>http://prostatecancerinfolink.net/2011/12/14/the-patients-expectations-and-the-doctors-dilemmas-3/</link>
		<comments>http://prostatecancerinfolink.net/2011/12/14/the-patients-expectations-and-the-doctors-dilemmas-3/#comments</comments>
		<pubDate>Thu, 15 Dec 2011 03:49:34 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Living with Prostate Cancer]]></category>
		<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[communication]]></category>
		<category><![CDATA[doctor]]></category>
		<category><![CDATA[patient]]></category>

		<guid isPermaLink="false">http://talkaboutprostatecancer.wordpress.com/?p=14636</guid>
		<description><![CDATA[The following article was just published by Ranjana Srivastava, MD, in The New England Journal of Medicine under the title &#8220;Dealing with uncertainty in a time of plenty.&#8221; The &#8220;New&#8221; Prostate Cancer InfoLink does not normally condone or practice the reproduction of copyrighted material. However, the following article has already been widely distributed on the [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=prostatecancerinfolink.net&amp;blog=3176292&amp;post=14636&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2011/12/14/the-patients-expectations-and-the-doctors-dilemmas-3/feed/</wfw:commentRss>
		<slash:comments>4</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>Informational event about prostate cancer screening on Capitol Hill</title>
		<link>http://prostatecancerinfolink.net/2011/11/29/informational-event-about-prostate-cancer-screening-on-capitol-hill/</link>
		<comments>http://prostatecancerinfolink.net/2011/11/29/informational-event-about-prostate-cancer-screening-on-capitol-hill/#comments</comments>
		<pubDate>Wed, 30 Nov 2011 01:40:16 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14558</guid>
		<description><![CDATA[From 12:00 noon to 01:00 p.m. on Wednesday, December 7,  the Men’s Health Caucus &#8212; Prostate Cancer Task Force and the Men’s Health Network will present “Prostate Cancer Screening: Dangerous or Life Saving?” (a lunch briefing about the controversy over screening for prostate cancer) in the Rayburn Building, B-340, on Capitol Hill in Washington, DC. [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=prostatecancerinfolink.net&amp;blog=3176292&amp;post=14558&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2011/11/29/informational-event-about-prostate-cancer-screening-on-capitol-hill/feed/</wfw:commentRss>
		<slash:comments>24</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
		<item>
		<title>NIH state-of-the-science conference on active surveillance</title>
		<link>http://prostatecancerinfolink.net/2011/11/18/nih-state-of-the-science-conference-on-active-surveillance/</link>
		<comments>http://prostatecancerinfolink.net/2011/11/18/nih-state-of-the-science-conference-on-active-surveillance/#comments</comments>
		<pubDate>Fri, 18 Nov 2011 15:09:10 +0000</pubDate>
		<dc:creator>Sitemaster</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://prostatecancerinfolink.net/?p=14458</guid>
		<description><![CDATA[A quick reminder &#8230; on December 5 to 7 the National Institutes of Health (NIH) is holding a State-of-the-Science Conference on the role of active surveillance and watchful waiting in the management of men with supposedly localized prostate cancer. It is free and open to the public or it can be monitored by web cast. This [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=prostatecancerinfolink.net&amp;blog=3176292&amp;post=14458&amp;subd=talkaboutprostatecancer&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://prostatecancerinfolink.net/2011/11/18/nih-state-of-the-science-conference-on-active-surveillance/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
	
		<media:content url="" medium="image">
			<media:title type="html">imperativa</media:title>
		</media:content>
	</item>
	</channel>
</rss>
